Endocrine Disruptors and Hypothalamic Sexual Differentiation

Detalhes bibliográficos
Autor(a) principal: Pereira, Oduvaldo C. M. [UNESP]
Data de Publicação: 2003
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.5016/1806-8774.2003v5p87
http://hdl.handle.net/11449/67526
Resumo: The so-called endocrine disruptors have been described as compounds which interfere with the estrogen action in their receptors and may exert a crucial role in the development of the reproductive tract and in the brain sexual differentiation. Thus, conducts and/or exposure to these drugs in the perinatal period that apparently do not endanger the neonate may cause side effects. During embrionary development, the gonads, through discharge of a small quantity of reproductive hormones, will guarantee the phenotype of male or female at birth, as well as actuate in specific areas sexual differentiation of the central nervous system. Several experimental models have shown an interference of drugs acting as endocrine disruptors in hypothalamic sexual differentiation. Thus, reproductive function is impaired by exposure to estrogen in the perinatal life of rats and the mechanisms involved in this effect are distinct for males and females. Perinatal exposure to drugs which may be considered endocrine disrupters may induce an incomplete masculinization and defeminization of the central nervous system. Alterations in these processes, if present, generally are perceived only at puberty or adult reproductive life. These later alterations may include anomalies in the process of fertility or in sexual behavior.
id UNSP_a1e3b026f01ca756d8b3bd0e06323c94
oai_identifier_str oai:repositorio.unesp.br:11449/67526
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Endocrine Disruptors and Hypothalamic Sexual DifferentiationBrain sexual differentiationEndocrine disruptorsEstrogenFertilityReproductive functionSexual behaviorantiandrogenendocrine disruptorenvironmental chemicalestrogenestrogen receptorunclassified drugxenobiotic agentembryo developmentestrogen activityfertilitygonadhypothalamusimmobilization stressnonhumanperinatal periodreproductionsex differentiationsexual behaviorshort surveyvirilizationThe so-called endocrine disruptors have been described as compounds which interfere with the estrogen action in their receptors and may exert a crucial role in the development of the reproductive tract and in the brain sexual differentiation. Thus, conducts and/or exposure to these drugs in the perinatal period that apparently do not endanger the neonate may cause side effects. During embrionary development, the gonads, through discharge of a small quantity of reproductive hormones, will guarantee the phenotype of male or female at birth, as well as actuate in specific areas sexual differentiation of the central nervous system. Several experimental models have shown an interference of drugs acting as endocrine disruptors in hypothalamic sexual differentiation. Thus, reproductive function is impaired by exposure to estrogen in the perinatal life of rats and the mechanisms involved in this effect are distinct for males and females. Perinatal exposure to drugs which may be considered endocrine disrupters may induce an incomplete masculinization and defeminization of the central nervous system. Alterations in these processes, if present, generally are perceived only at puberty or adult reproductive life. These later alterations may include anomalies in the process of fertility or in sexual behavior.Instituto de Biociências UNESPDepartamento de Farmacologia Instituto de Biociências UNESP, 18618-000, Botucatu, SPInstituto de Biociências UNESPDepartamento de Farmacologia Instituto de Biociências UNESP, 18618-000, Botucatu, SPUniversidade Estadual Paulista (Unesp)Pereira, Oduvaldo C. M. [UNESP]2014-05-27T11:20:58Z2014-05-27T11:20:58Z2003-12-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article87-94application/pdfhttp://dx.doi.org/10.5016/1806-8774.2003v5p87Annual Review of Biomedical Sciences, v. 5, p. 87-94.1806-8774http://hdl.handle.net/11449/6752610.5016/1806-8774.2003v5p872-s2.0-19424247472-s2.0-1942424747.pdfScopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengAnnual Review of Biomedical Sciencesinfo:eu-repo/semantics/openAccess2024-01-03T06:20:56Zoai:repositorio.unesp.br:11449/67526Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-01-03T06:20:56Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Endocrine Disruptors and Hypothalamic Sexual Differentiation
title Endocrine Disruptors and Hypothalamic Sexual Differentiation
spellingShingle Endocrine Disruptors and Hypothalamic Sexual Differentiation
Pereira, Oduvaldo C. M. [UNESP]
Brain sexual differentiation
Endocrine disruptors
Estrogen
Fertility
Reproductive function
Sexual behavior
antiandrogen
endocrine disruptor
environmental chemical
estrogen
estrogen receptor
unclassified drug
xenobiotic agent
embryo development
estrogen activity
fertility
gonad
hypothalamus
immobilization stress
nonhuman
perinatal period
reproduction
sex differentiation
sexual behavior
short survey
virilization
title_short Endocrine Disruptors and Hypothalamic Sexual Differentiation
title_full Endocrine Disruptors and Hypothalamic Sexual Differentiation
title_fullStr Endocrine Disruptors and Hypothalamic Sexual Differentiation
title_full_unstemmed Endocrine Disruptors and Hypothalamic Sexual Differentiation
title_sort Endocrine Disruptors and Hypothalamic Sexual Differentiation
author Pereira, Oduvaldo C. M. [UNESP]
author_facet Pereira, Oduvaldo C. M. [UNESP]
author_role author
dc.contributor.none.fl_str_mv Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Pereira, Oduvaldo C. M. [UNESP]
dc.subject.por.fl_str_mv Brain sexual differentiation
Endocrine disruptors
Estrogen
Fertility
Reproductive function
Sexual behavior
antiandrogen
endocrine disruptor
environmental chemical
estrogen
estrogen receptor
unclassified drug
xenobiotic agent
embryo development
estrogen activity
fertility
gonad
hypothalamus
immobilization stress
nonhuman
perinatal period
reproduction
sex differentiation
sexual behavior
short survey
virilization
topic Brain sexual differentiation
Endocrine disruptors
Estrogen
Fertility
Reproductive function
Sexual behavior
antiandrogen
endocrine disruptor
environmental chemical
estrogen
estrogen receptor
unclassified drug
xenobiotic agent
embryo development
estrogen activity
fertility
gonad
hypothalamus
immobilization stress
nonhuman
perinatal period
reproduction
sex differentiation
sexual behavior
short survey
virilization
description The so-called endocrine disruptors have been described as compounds which interfere with the estrogen action in their receptors and may exert a crucial role in the development of the reproductive tract and in the brain sexual differentiation. Thus, conducts and/or exposure to these drugs in the perinatal period that apparently do not endanger the neonate may cause side effects. During embrionary development, the gonads, through discharge of a small quantity of reproductive hormones, will guarantee the phenotype of male or female at birth, as well as actuate in specific areas sexual differentiation of the central nervous system. Several experimental models have shown an interference of drugs acting as endocrine disruptors in hypothalamic sexual differentiation. Thus, reproductive function is impaired by exposure to estrogen in the perinatal life of rats and the mechanisms involved in this effect are distinct for males and females. Perinatal exposure to drugs which may be considered endocrine disrupters may induce an incomplete masculinization and defeminization of the central nervous system. Alterations in these processes, if present, generally are perceived only at puberty or adult reproductive life. These later alterations may include anomalies in the process of fertility or in sexual behavior.
publishDate 2003
dc.date.none.fl_str_mv 2003-12-01
2014-05-27T11:20:58Z
2014-05-27T11:20:58Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.5016/1806-8774.2003v5p87
Annual Review of Biomedical Sciences, v. 5, p. 87-94.
1806-8774
http://hdl.handle.net/11449/67526
10.5016/1806-8774.2003v5p87
2-s2.0-1942424747
2-s2.0-1942424747.pdf
url http://dx.doi.org/10.5016/1806-8774.2003v5p87
http://hdl.handle.net/11449/67526
identifier_str_mv Annual Review of Biomedical Sciences, v. 5, p. 87-94.
1806-8774
10.5016/1806-8774.2003v5p87
2-s2.0-1942424747
2-s2.0-1942424747.pdf
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Annual Review of Biomedical Sciences
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 87-94
application/pdf
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1803650156302696448